132.2 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 132.2 for the 75–79 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
68 evidence items · page 2 / 3
22.5 %The percentage distribution of cervical cancer by severity stage in Senegal was 22.5% for stage IV.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
58.1 %The percentage distribution of high-risk HPV genotypes 16/18 among invasive cervical cancer cases in Senegal was 58.1%.
Sénégalcancer du col de l'utérus · HPV genotypes 16/18HAL · Unilimdocument of 111 observations
The distribution of cervical cancer cases by stage in Senegal was based on previously reported estimates for Senegal.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
16 %A one-dose Cecolin strategy with 90% coverage achieved a 16% reduction in cervical cancer risk in Senegal.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
130,204 casesIf HPV vaccination coverage in Senegal remains at current levels with Gardasil-4 and no further improvements are made, it is projected that 130,204 girls will develop cervical cancer over their lifetimes.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
15.85 %Strategies 17 and 21, which involve Cecolin under the WHO 90% coverage target, lead to reductions in disability-adjusted life years (DALYs) of 15.85% and 11.83%, respectively.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
10 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 10.0 for the 35–39 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
115.8 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 115.8 for the 70–74 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
10 %Only 10% of Senegalese women have ever been screened for cervical cancer.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
32 %The one-dose Gardasil-9 strategy at WHO coverage could reduce cervical cancer incidence by up to 32%.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
29.2 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 29.2 for the 45–49 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
84.46 %The percentage distribution of high-risk HPV genotypes 16/18/31/33/45/52/58 among invasive cervical cancer cases in Senegal was 84.46%.
Sénégalcancer du col de l'utérus · HPV genotypes 16/18/31/33/45/52/58HAL · Unilimdocument of 111 observations
44.2 %The percentage distribution of cervical cancer by severity stage in Senegal was 44.2% for stage III.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
50.3 %Estimated average five-year survival rates in Senegal for cervical cancer are 50.3% for local stage, 20.5% for regional stage, and 0.0% for distant stage.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
61,000,000 USDThe total cost of cervical cancer-related treatment is estimated at USD 61 million over the lifetimes of 16 cohorts of 9-year-old girls in Senegal under the baseline Gardasil-4 scenario.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
47 %The one-dose Gardasil-9 strategy at WHO coverage is associated with a 47% increase in costs.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
1,000 casSelon la Ligue sénégalaise de lutte contre le Cancer (LISCA), environ 1 000 nouveaux cas de cancer du col de l'utérus sont enregistrés chaque année au Sénégal.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 857 observations
69.5 per_100000The annual rate of cervical cancer cases per 100,000 females in Senegal was 69.5 for the 45–49 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
40.2 per_100000The annual rate of cervical cancer cases per 100,000 females in Senegal was 40.2 for the 35–39 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
3,713.45 USDThe direct medical cost of cervical cancer treatment in Senegal was estimated to have an average of USD 3713.45.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
100,000 per_100000_femalesThe age-specific incidence of cervical cancer is presented by stage, based on annual rates per 100,000 females.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
26.6 per_100000The annual rate of cervical cancer cases per 100,000 females in Senegal was 26.6 for the 30–34 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
1 per_100000The annual rate of cervical cancer deaths per 100,000 females in Senegal was 1.0 for the 25–29 years age group, according to GLOBOCAN 2022.
Sénégalcancer du col de l'utérusobserved 2022HAL · Unilimdocument of 111 observations
112,866 DALYsStrategy 19, using Gardasil 9 with 90% coverage, achieved the greatest health benefit, averting 112,866 DALYs.
Sénégalcancer du col de l'utérusHAL · Unilimdocument of 111 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.